Related Experiment Video
Updated: Nov 28, 2025

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Determinants of short-term outcomes after pediatric liver transplantation: a single centre experience over 20 years
Olivier Boillot1, Olivier Guillaud2, Gabriella Pittau3
1Department of Digestive Diseases, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France; University Claude Bernard Lyon 1, Lyon, France.
Insights
Pediatric liver transplantation (LT) outcomes depend on factors like initial liver disease and donor/recipient age difference. Understanding these prognostic factors improves decision-making for children needing LT.
Area of Science:
- Pediatric surgery
- Hepatology
- Transplant immunology
Background:
- Liver transplantation (LT) is a critical treatment for children with end-stage liver disease.
- Postoperative outcomes in pediatric LT are influenced by disease severity, donor type, and graft characteristics.
Purpose of the Study:
- To identify prognostic factors influencing 1-year patient and graft survival in pediatric liver transplant recipients.
- To analyze a large single-center cohort of children undergoing liver transplantation.
Main Methods:
- Retrospective analysis of 151 children undergoing their first LT between October 1990 and October 2010.
- Multivariate analysis to determine significant associations with patient and graft survival.
Main Results:
- One-year patient and graft survival rates were 88.7% and 86.1%, respectively.
- Key factors associated with patient survival included initial liver disease, location at LT, donor/recipient delta age, early post-transplant hemodialysis, and initial immunosuppression.
- Graft survival was linked to donor/recipient delta age, primary non-function, early post-transplant hemodialysis, and initial immunosuppression.
Conclusions:
- Early patient and graft survival in pediatric LT are significantly influenced by pre-operative and operative factors.
- Identifying prognostic indicators such as initial liver disease, donor/recipient age difference, and immunosuppressive strategies is crucial for optimizing pediatric LT outcomes.
Background:
Liver transplantation (LT) is a standard-of-care therapeutic modality for selected patients with life-threatening liver disease, including children. In addition to specific clinical characteristics of pediatric LT recipients due to initial liver disease (and related comorbidities) and level of liver failure, early postoperative outcome may be dependent on the surgical technique used, related to the type of organ donor and graft. Therefore, the aims of the present retrospective study from a large single centre cohort were to identify the prognostic factors for both 1-year patient and graft survival.
Methods:
Between October 1990 and October 2010, 151 children underwent a first LT in our centre.
Results:
The mean age was 5.3 ± 7.4 years, and the main indication was biliary atresia (BA) (49.0%). Living donor liver transplantation (LDLT) was performed in 39 cases (25.8%). Cadaveric liver graft was a whole liver in 50 cases (33.1%) and a partial liver (reduced or split) in 62 cases (41.1%). One-year patient and graft survival rates were 88.7% and 86.1%, respectively. Multivariate analysis disclosed that initial liver disease, location at time of LT, donor/recipient (D/R) delta age, early post-transplant hemodialysis and initial immunosuppression (induction) were significantly associated with patient survival and that D/R delta age, primary non-function, early post-transplant hemodialysis and initial immunosuppression (induction) were significantly associated with graft survival.
Conclusion:
The results of our single-centre experience of pediatric LT emphasize that early patient and graft survivals depend on pre-operative/operative factors such as initial liver disease, D/R delta age and immunosuppressive regimen. Awareness of these factors can help in the decision making for children requiring LT.
Related Concept Videos
Kidney Transplant I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management

